The AMH test is a key fertility diagnostic tool used to evaluate ovarian reserve by measuring levels of anti-Müllerian hormone in the blood. AMH is produced by small follicles in the ovaries and reflects the remaining quantity of eggs. Because AMH levels remain relatively stable throughout the menstrual cycle, the test can be performed on any day, making it a convenient and reliable biomarker for fertility assessment. The test is performed through a simple blood draw and provides valuable insight into ovarian reserve, expected response to fertility treatments, and reproductive planning. AMH levels help estimate how the ovaries may respond to ovarian stimulation in assisted reproduction and can offer information about proximity to menopause when interpreted in the appropriate clinical context. At Avida Fertility, AMH testing is interpreted using a comprehensive, personalized approach. While AMH is a crucial indicator, it is not evaluated in isolation. Results are considered alongside age, follicle-stimulating hormone (FSH) levels, estradiol levels, and antral follicle count assessed by ultrasound to provide a complete picture of ovarian reserve. The process begins with a specialist consultation, during which medical history, reproductive goals, family history of early menopause, prior ovarian surgery, and other risk factors for diminished ovarian reserve are reviewed. The blood sample is obtained from a vein in the arm using sterile technique and takes less than five minutes, with minimal discomfort. No fasting, cycle timing, or special preparation is required, and hormonal contraceptives do not affect AMH results. Samples are analyzed in a specialized laboratory using immunoassay techniques that precisely measure AMH concentration. Results are typically available within 2–7 business days and are reported in nanograms per milliliter (ng/ml). Fertility specialists then provide a personalized interpretation based on age and overall reproductive context, explaining what the results mean for current fertility potential and future options. Based on AMH results and the broader fertility evaluation, patients receive individualized guidance that may include fertility preservation strategies, reproductive planning, personalized fertility treatments, or regular monitoring. The AMH test empowers patients with clarity and information to make informed decisions about their reproductive future.